Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):325–334. doi: 10.1111/j.1476-5381.1996.tb15406.x

Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.

S M Gardiner 1, J E March 1, P A Kemp 1, T Bennett 1
PMCID: PMC1909622  PMID: 8735634

Abstract

1. Male, vasopressin-deficient, normotensive (DI/N) and hypertensive (DI/H) rats were chronically instrumented (all surgery under sodium methohexitone anaesthesia) to allow assessment of resting haemodynamic status and responses to antagonism of AT1-receptors (Experiment 1), ET(A-) and ET(B-) receptors (Experiment 2) or adrenoceptors (Experiment 3). 2. Before any treatment, mean arterial blood pressure (MAP) was higher, and hindquarters vascular conductance was consistently lower in all groups of DI/H rats than in DI/N rats. 3. In Experiment 1, losartan (10 mg kg-1 i.v.), an AT1-receptor antagonist, was given 5 h after s.c. injection of saline, (DI/N, n = 8; DI/H, n = 8) or hyperoncotic polyethylene glycol, (DI/N, n = 9; DI/H, n = 9) to induce isosmotic hypovolaemia. In the volume-replete state, losartan caused similar small falls in MAP in the two groups (maximum delta MAP; DI/N, -9 +/- 2; DI/H, -15 +/- 5 mmHg), but the mesenteric and hindquarters vasodilatations were greater in DI/N rats. In the volume-depleted state the effects of losartan were augmented (delta MAP; DI/N, -32 +/- 3; DI/H. -31 +/- 3 mmHg), but its vasodilator effects were still greater in DI/N than in DI/H rats. 4. In Experiment 2, infusion of the ET(A-)ET(B-)receptor antagonist, SB 209670 (600 micrograms kg-1 h-1; DI/N, n = 8; DI/H, n = 9), had haemodynamic effects that were not different from those during saline infusion in DI/N (n = 7) and DI/H rats (n = 8). 5. In Experiment 3, sequential administration of the beta 2-adrenoceptor antagonist, ICI 118551 (0.2 mg kg-1 bolus, 0.1 mg kg-1 h-1 infusion), the alpha 2-adrenoceptor antagonist, idazoxan (0.75 mg kg-1 bolus, 1 mg kg-1 h-1 infusion), and losartan (10 mg kg-1 bolus) had only slight haemodynamic effects in DI/N (n = 8) and DI/H (n = 9) rats. Subsequent administration of the alpha 1-adrenoceptor antagonist, prazosin (0.5 mg kg-1 bolus, 0.8 mg kg-1 h-1 infusion) caused marked hypotension, although MAP was still higher in DI/H (95 +/- 4 mmHg) than in DI/N (75 +/- 4 mmHg) rats. However, in this circumstance there were no significant differences between renal, or mesenteric, or hindquarters vascular conductances in the two groups. 6. The results indicate that the hypertension and hindquarters vasoconstriction in DI/H rats is not dependent on AII or endothelin. Moreover, the relative elevation in MAP in DI/H persists in the presence of antagonism of beta 2, alpha 2- and alpha 1-adrenoceptors, in spite of no significant difference in regional vascular conductances.

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashton N., Balment R. J. Blood pressure and renal function in a novel vasopressin-deficient, genetically hypertensive rat strain. J Physiol. 1989 Mar;410:21–34. doi: 10.1113/jphysiol.1989.sp017518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Batin P., Gardiner S. M., Compton A. M., Bennett T. Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci. 1991;48(8):733–739. doi: 10.1016/0024-3205(91)90087-r. [DOI] [PubMed] [Google Scholar]
  3. Batin P., Gardiner S. M., Compton A. M., Kemp P. A., Bennett T. Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats. Br J Pharmacol. 1991 Jun;103(2):1585–1591. doi: 10.1111/j.1476-5381.1991.tb09831.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Berecek K. H., Murray R. D., Gross F., Brody M. J. Vasopressin and vascular reactivity in the development of DOCA hypertension in rats with hereditary diabetes insipidus. Hypertension. 1982 Jan-Feb;4(1):3–12. doi: 10.1161/01.hyp.4.1.3. [DOI] [PubMed] [Google Scholar]
  5. Chen L., McNeill J. R., Wilson T. W., Gopalakrishnan V. Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels. Br J Pharmacol. 1995 Apr;114(8):1599–1604. doi: 10.1111/j.1476-5381.1995.tb14945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Crofton J. T., Share L., Shade R. E., Lee-Kwon W. J., Manning M., Sawyer W. H. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1979 Jan-Feb;1(1):31–38. doi: 10.1161/01.hyp.1.1.31. [DOI] [PubMed] [Google Scholar]
  7. Dohi Y., Hahn A. W., Boulanger C. M., Bühler F. R., Lüscher T. F. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension. 1992 Feb;19(2):131–137. doi: 10.1161/01.hyp.19.2.131. [DOI] [PubMed] [Google Scholar]
  8. Douglas S. A., Gellai M., Ezekiel M., Feuerstein G. Z., Elliott J. D., Ohlstein E. H. Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension. 1995 Apr;25(4 Pt 2):818–822. doi: 10.1161/01.hyp.25.4.818. [DOI] [PubMed] [Google Scholar]
  9. Dunn W. R., Gardiner S. M. Structural and functional properties of isolated, pressurized, mesenteric resistance arteries from a vasopressin-deficient rat model of genetic hypertension. Hypertension. 1995 Sep;26(3):390–396. doi: 10.1161/01.hyp.26.3.390. [DOI] [PubMed] [Google Scholar]
  10. Emori T., Hirata Y., Ohta K., Kanno K., Eguchi S., Imai T., Shichiri M., Marumo F. Cellular mechanism of endothelin-1 release by angiotensin and vasopressin. Hypertension. 1991 Aug;18(2):165–170. doi: 10.1161/01.hyp.18.2.165. [DOI] [PubMed] [Google Scholar]
  11. Gardiner S. M., Bennett T., Compton A. M. Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst. 1988 Sep;24(1-2):15–27. doi: 10.1016/0165-1838(88)90131-2. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Bennett T. Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats. Clin Sci (Lond) 1985 Jun;68(6):647–657. doi: 10.1042/cs0680647. [DOI] [PubMed] [Google Scholar]
  13. Gardiner S. M., Bennett T. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Jan;93(1):9–22. doi: 10.1111/j.1476-5381.1988.tb11400.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gardiner S. M., Bennett T. Pressor contributions from angiotensin and vasopressin after polyethylene glycol. Am J Physiol. 1986 Oct;251(4 Pt 2):R769–R774. doi: 10.1152/ajpregu.1986.251.4.R769. [DOI] [PubMed] [Google Scholar]
  15. Gardiner S. M., Bennett T. Regional hemodynamic responses to adrenoceptor antagonism in conscious rats. Am J Physiol. 1988 Oct;255(4 Pt 2):H813–H824. doi: 10.1152/ajpheart.1988.255.4.H813. [DOI] [PubMed] [Google Scholar]
  16. Gardiner S. M., Compton A. M., Bennett T., Hartley C. J. Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats? Am J Physiol. 1990 Aug;259(2 Pt 2):H448–H456. doi: 10.1152/ajpheart.1990.259.2.H448. [DOI] [PubMed] [Google Scholar]
  17. Gardiner S. M., Compton A. M., Bennett T. Regional hemodynamic changes following hypovolemia in conscious rats. Am J Physiol. 1989 May;256(5 Pt 2):R1076–R1083. doi: 10.1152/ajpregu.1989.256.5.R1076. [DOI] [PubMed] [Google Scholar]
  18. Gardiner S. M., March J. E., Kemp P. A., Bennett T. Resting cardiovascular status and vasodilator function in a vasopressin-deficient, hypertensive strain of rat. J Hypertens. 1994 Nov;12(11):1217–1224. [PubMed] [Google Scholar]
  19. Haywood J. R., Shaffer R. A., Fastenow C., Fink G. D., Brody M. J. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat. Am J Physiol. 1981 Aug;241(2):H273–H278. doi: 10.1152/ajpheart.1981.241.2.H273. [DOI] [PubMed] [Google Scholar]
  20. Imai T., Hirata Y., Emori T., Yanagisawa M., Masaki T., Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992 Jun;19(6 Pt 2):753–757. doi: 10.1161/01.hyp.19.6.753. [DOI] [PubMed] [Google Scholar]
  21. Kohno M., Horio T., Ikeda M., Yokokawa K., Fukui T., Yasunari K., Kurihara N., Takeda T. Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells. Kidney Int. 1992 Oct;42(4):860–866. doi: 10.1038/ki.1992.361. [DOI] [PubMed] [Google Scholar]
  22. Kohno M., Yasunari K., Yokokawa K., Murakawa K., Horio T., Takeda T. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. J Clin Invest. 1991 Jun;87(6):1999–2004. doi: 10.1172/JCI115228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lautt W. W. Resistance or conductance for expression of arterial vascular tone. Microvasc Res. 1989 Mar;37(2):230–236. doi: 10.1016/0026-2862(89)90040-x. [DOI] [PubMed] [Google Scholar]
  24. Mancia G., Ferrari A., Gregorini L., Parati G., Ferrari M. C., Pomidossi G., Zanchetti A. Control of blood pressure by carotid sinus baroreceptors in human beings. Am J Cardiol. 1979 Oct 22;44(5):895–902. doi: 10.1016/0002-9149(79)90220-0. [DOI] [PubMed] [Google Scholar]
  25. Muller A. F., Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin Sci (Lond) 1990 Oct;79(4):393–401. doi: 10.1042/cs0790393. [DOI] [PubMed] [Google Scholar]
  26. Mullins J. J., Peters J., Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature. 1990 Apr 5;344(6266):541–544. doi: 10.1038/344541a0. [DOI] [PubMed] [Google Scholar]
  27. O'Leary D. S. Regional vascular resistance vs. conductance: which index for baroreflex responses? Am J Physiol. 1991 Feb;260(2 Pt 2):H632–H637. doi: 10.1152/ajpheart.1991.260.2.H632. [DOI] [PubMed] [Google Scholar]
  28. Sharabi F. M., Schmid P. G. Evidence for a role of vasopressin in hypertension. Am J Nephrol. 1983 Mar-Jun;3(2-3):164–171. doi: 10.1159/000166706. [DOI] [PubMed] [Google Scholar]
  29. Stark R. D. Conductance or resistance? Nature. 1968 Feb 24;217(5130):779–779. doi: 10.1038/217779a0. [DOI] [PubMed] [Google Scholar]
  30. Yoshida K., Yasujima M., Kohzuki M., Kanazawa M., Yoshinaga K., Abe K. Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension. 1992 Sep;20(3):292–297. doi: 10.1161/01.hyp.20.3.292. [DOI] [PubMed] [Google Scholar]
  31. al-Barazanji K. A., Balment R. J. Renal, endocrine and vascular effects of atrial natriuretic peptide in a novel vasopressin-deficient genetically hypertensive strain of rat. Exp Physiol. 1995 Mar;80(2):275–284. doi: 10.1113/expphysiol.1995.sp003847. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES